SecBot SecBot
6-K ·Filed Jun 3, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001575872-26-000395
Notable filing: 6-K
Actionable Insight • Neutral

No actionable trading signal, this is a routine investor relations update. Monitor for any material disclosures that may emerge from the conferences, but no immediate action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$13.02
T+0 close · Jun 3, 2026 · via day close
Latest settled
−6.61%
T+60 · $12.16
Vs SPY
−9.10%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 3 $13.02entry
  2. T+1 · 6mo ago +1.69%α +1.29% · $13.24
  3. T+5 · 5mo ago +2.15%α +5.97% · $13.30
  4. T+20 · 5mo ago +10.45%α +11.45% · $14.38
  5. T+60 · 3mo ago −6.61%α −9.10% · $12.16

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's filed a Form 6-K on June 3, 2026, disclosing that management will participate in two investor conferences: a group meeting organized by ICICI Securities in Mumbai on June 9, 2026, and a group meeting organized by Macquarie in Hyderabad on June 10, 2026. This is a routine disclosure of investor relations activities with no material financial information.

Key Facts

  • Management to participate in ICICI Securities group meeting in Mumbai on June 9, 2026
  • Management to participate in Macquarie group meeting in Hyderabad on June 10, 2026
  • Both meetings are in-person group meetings with institutional investors
  • No material financial data, guidance, or business developments disclosed

Financial Impact

No financial impact, routine investor conference participation with no material disclosures

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000395
Document: 0001575872-26-000395-index.html0001575872-26-000395
Document: 0001575872-26-000395.txt0001575872-26-000395

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026